Streetbeat News

Products Services

BMRN

BioMarin Pharmaceutical Inc. presented positive real-world evidence supporting the safety and efficacy of VOXZOGO® (vosoritide) for children with achondroplasia at the ESPE Meeting 2024.

Portfolio Pulse from

November 16, 2024 | 4:00 pm

MDCX

Medicus Pharma has successfully listed on Nasdaq, raising $4 million through its IPO to fund a Phase 2 trial for a noninvasive basal cell carcinoma treatment.

Portfolio Pulse from

November 16, 2024 | 3:00 pm

DNLI

Denali Therapeutics is leveraging its unique blood-brain barrier technology and strategic partnerships to gain an edge in the neurodegenerative disease market. With a strong cash position, Denali is well-positioned to advance its R&D and commercialization efforts without needing immediate additional funding.

Portfolio Pulse from

November 16, 2024 | 2:15 pm

ORIC

ORIC Pharmaceuticals, a small-cap pharma stock listed on NASDAQ, is collaborating with two major pharmaceutical companies. Analysts predict a potential upside of over 100% for ORIC due to its promising 'best-in-class' treatments.

Portfolio Pulse from

November 16, 2024 | 2:15 pm

ONON

On Holding, a prominent player in the sports industry, is experiencing significant growth momentum, indicating a promising future for the company.

Portfolio Pulse from

November 16, 2024 | 2:15 pm

AMGN

The article discusses reasons to buy Amgen stock, highlighting its bright future, while also noting a reason for caution. It suggests that while Amgen has potential, investors should be aware of possible challenges.

Portfolio Pulse from

November 16, 2024 | 2:00 pm

CMCL

Caledonia Mining Corporation PLC reported steady gold production of 19,000oz in the third quarter, aligning with its annual targets. The company is focusing on further efficiency improvements.

Portfolio Pulse from

November 16, 2024 | 2:00 pm

AXON

Axon Enterprises reported strong Q3 earnings with significant growth in its Taser business and software, leading to a stock price of $600 per share. The company's innovative AI tools and international opportunities suggest long-term growth, but the current high valuation makes it a hold.

Portfolio Pulse from

November 16, 2024 | 2:00 pm

GE

LMT

NOC

RTX

The article discusses the impact of market uncertainty on defense stocks, particularly Lockheed Martin and Northrop Grumman, due to Trump's controversial appointments. The author sees a buying opportunity in the defense sector, focusing on innovative companies like RTX and GE Aerospace.

Portfolio Pulse from

November 16, 2024 | 1:45 pm